clinivation, Inc. -

Innovative radiotherapy firm readies for growth with clinivation's Quality Systems infrastructure and process solutions.

Framingham, MA, August 31, 2001 - clinivation, Inc. announced today that Photoelectron Corporation (AMEX: PHX) has selected clinivation's quality systems infrastructure and process solutions.

"Photoelectron is an emerging leader in innovative, value-added radiotherapy systems for breast cancer and other important medical needs, " said Joseph Kozikowski, M.D., clinivation's Chairman and Chief Technology Officer. "We are pleased that Photoelectron's senior management has selected clinivation to help extend their quality systems and position their manufacturing and development operations for continued growth and expansion," he continued.

Clinivation's rapidly-implementable quality systems infrastructure solutions are pre-configured, matched to specific client needs, and designed to scale with product history and organization growth.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com